Danaher Corporation (NYSE:DHR) Shares Sold by M&T Bank Corp

M&T Bank Corp lowered its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 7.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 459,054 shares of the conglomerate's stock after selling 36,621 shares during the period. M&T Bank Corp owned 0.06% of Danaher worth $94,106,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. GHP Investment Advisors Inc. lifted its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. Sierra Ocean LLC lifted its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new position in Danaher during the first quarter worth about $31,000. Finally, Rialto Wealth Management LLC purchased a new position in Danaher during the fourth quarter worth about $34,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent analyst reports. The Goldman Sachs Group reduced their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Guggenheim reiterated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Argus reduced their target price on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. cut their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Finally, Evercore ISI cut their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $248.43.

Danaher Stock Down 0.3%

Shares of NYSE:DHR traded down $0.71 during mid-day trading on Friday, hitting $204.80. 2,369,010 shares of the company traded hands, compared to its average volume of 3,504,283. The firm has a market cap of $146.57 billion, a P/E ratio of 39.77, a PEG ratio of 2.89 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The firm's 50 day simple moving average is $196.05 and its 200 day simple moving average is $206.47.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Insider Buying and Selling

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.